ABSTRACT OBJECTIVES This study sought to investigate the prevalence of abnormal von Willebrand multimers (AbM) in patients undergoing transcatheter aortic valve replacement (TAVR) and the impact of TAVR on the underlying factor variances.
decreased content of the high-molecular-weight multimers (HMWM) and severity of the AS, along with a correction of the multimer content 1 day after SAVR (6,7) was described. Currently transcatheter aortic valve replacement (TAVR) is an alternative to SAVR for selected patients (8) with superior outcomes in specified populations (9) . Nevertheless, the influence on a shear stress-induced loss of HMWM in patients undergoing TAVR has not been investigated comprehensively. However, greater age, multimorbidity, and the necessity of dual antiplatelet therapy possibly leading to a substantial increase in bleeding risk are characteristic of patients envisaged for TAVR (10) .
Hence, a comprehensive understanding of the prevalence and the impact of TAVR on the hemostaseologic peculiarities in this population was the aim of the present work. (n ¼ 51), the Edwards Centera valve (n ¼ 13) and St.
Jude Portico valve (St. Jude Medical, St. Paul, Minnesota) (n ¼ 1) were used as previously described (11) (12) (13) (14) . After valve deployment, the final transvalvular gradient was measured invasively (i.e., simultaneous recording with a pigtail in the left ventricle and a second pigtail in the ascending aorta) and a standardized root angiography (30 cc/ 15 cc/s) was performed to assess the extent of aortic regurgitation.
All patients received acetylsalicylic acid 100 mg, before the procedure and continued indefinitely.
A 600 mg loading dose of clopidogrel was administered the day before the procedure, followed by 75 mg tance, and pulmonary vascular resistance index, were determined using the thermodilution method. Finally, the aortic valve area using the Gorlin formula (15, 16) and the valvuloarterial impedance (Zva), the systemic arterial compliance (SAC) (17) , and the transpulmonary gradient were calculated immediately before and after TAVR. 
A P R I L 2 7 , 2 0 1 5 : 6 9 2 -7 0 0 Multimer analysis was performed as described before (19) in gels of low (1.2%) and medium resolution (1.6%;
LGT agarose type VII, Sigma, Munich, Germany). Plasma samples were classified as either 
HMWM (%)
Change of high-molecular-weight multimers (HMWM) in abnormal multimer (AbM) and normal multimer (NM) patients over time. Abbreviations as in Figure 2 . Abbreviations as in Figure 2 . High-molecular-weight multimer (HMWM) increase following transcatheter aortic valve replacement relative to reduction of mean transvalvular gradient for the abnormal multimer and normal multimer (NM) groups. dPmean ¼ mean transvalvular gradient. Abbreviations as in Figure 2 . .
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von Willebrand Multimers and TAVR is defined as a pathological distribution (AbM). 
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A P R I L 2 7 , 2 0 1 5 : 6 9 2 -7 0 0 HEMODYNAMICS. Hemodynamic data is presented in Table 2 . implantation thrombocytopenia soluble P-selectin levels were measured by enzyme-linked immunosorbent assay, but found to be within normal limits in all patients and at all time points (data not shown). Spangenberg et al.
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